Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study.

Oncologist · 2025 · PMC12921449 · PMID 41330714

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Among the tumor tests, the prevalence of HRR alterations was higher in the mCRPC population (mCRPC vs mHSPC, 18.1% vs 13.8%, respectively; P = .06), although the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.